Journal of oral biosciences · 2025
Dipeptidyl peptidase from Streptococcus anginosus with substrate specificity for Xaa-Pro/Ala and potential impact on tumor immunity.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Suzuki Shu, Miura Toshitaka, Shimoyama Yu, Ohara-Nemoto Yuko, Nemoto Takayuki K, Yamada Hiroyuki, Ishikawa Taichi
Аннотация
OBJECTIVES: Streptococcus anginosus, an oral commensal bacterium, is a potential risk factor for malignancies of the oral cavity and upper gastrointestinal tract. Although this species harbors an Xaa-Pro dipeptidyl peptidase (DPP), its enzymatic characteristics and potential role in tumor-associated immune modulation remain unclear. In this study, S. anginosus Xaa-Pro DPP was characterized and its ability to cleave chemokine-related peptides was evaluated.
METHODS: Six oral streptococcal strains were analyzed for DPP activity using fluorogenic dipeptidyl substrates. The gene encoding S. anginosus Xaa-Pro DPP was cloned and the recombinant enzyme was purified and characterized. The enzymatic activity of the peptidase against synthetic dipeptidyl 7-amino-4-methylcoumarin (MCA) and chemokine-derived peptides was assessed using fluorescence assays and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. The effect of the DPP4 inhibitor, P32/98, was also examined.
RESULTS: S. anginosus had the highest DPP activity among the tested oral streptococci, particularly towards Gly-Pro- and Lys-Ala-MCA. The recombinant enzyme selectively removed Xaa-Pro and Xaa-Ala dipeptides and the N-terminal Lys-Pro dipeptide from the CXCL12-derived peptide, whereas incretins were minimally affected. The enzymatic activity of Xaa-Pro DPP against synthetic substrates was markedly inhibited by P32/98.
CONCLUSION: S. anginosus Xaa-Pro DPP has specificity for N-terminal Xaa-Pro/Ala in peptides and exhibits the ability to inactivate chemokine-related peptides, suggesting a potential contribution to immune dysregulation in the tumor microenvironment.
METHODS: Six oral streptococcal strains were analyzed for DPP activity using fluorogenic dipeptidyl substrates. The gene encoding S. anginosus Xaa-Pro DPP was cloned and the recombinant enzyme was purified and characterized. The enzymatic activity of the peptidase against synthetic dipeptidyl 7-amino-4-methylcoumarin (MCA) and chemokine-derived peptides was assessed using fluorescence assays and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. The effect of the DPP4 inhibitor, P32/98, was also examined.
RESULTS: S. anginosus had the highest DPP activity among the tested oral streptococci, particularly towards Gly-Pro- and Lys-Ala-MCA. The recombinant enzyme selectively removed Xaa-Pro and Xaa-Ala dipeptides and the N-terminal Lys-Pro dipeptide from the CXCL12-derived peptide, whereas incretins were minimally affected. The enzymatic activity of Xaa-Pro DPP against synthetic substrates was markedly inhibited by P32/98.
CONCLUSION: S. anginosus Xaa-Pro DPP has specificity for N-terminal Xaa-Pro/Ala in peptides and exhibits the ability to inactivate chemokine-related peptides, suggesting a potential contribution to immune dysregulation in the tumor microenvironment.